Display options
Cite
Brogden KA, Parashar D, Hallier AR, et al. Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer. 2018;18(1):413doi: 10.1186/s12885-018-4200-5.
Brogden, K. A., Parashar, D., Hallier, A. R., Braun, T., Qian, F., Rizvi, N. A., Bossler, A. D., Milhem, M. M., Chan, T. A., Abbasi, T., & Vali, S. (2018). Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC cancer, 18(1), 413. https://doi.org/10.1186/s12885-018-4200-5
Brogden, Kim A, et al. "Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy." BMC cancer vol. 18,1 (2018): 413. doi: https://doi.org/10.1186/s12885-018-4200-5
Brogden KA, Parashar D, Hallier AR, Braun T, Qian F, Rizvi NA, Bossler AD, Milhem MM, Chan TA, Abbasi T, Vali S. Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer. 2018 Apr 12;18(1):413. doi: 10.1186/s12885-018-4200-5. PMID: 29649990; PMCID: PMC5898039.
Copy Download .nbib Format: NLM
Share it on

BMC Cancer. 2018 Apr 12;18(1):413. doi: 10.1186/s12885-018-4200-5.

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.

BMC cancer

Kim A Brogden, Deepak Parashar, Andrea R Hallier, Terry Braun, Fang Qian, Naiyer A Rizvi, Aaron D Bossler, Mohammed M Milhem, Timothy A Chan, Taher Abbasi, Shireen Vali

Affiliations

  1. Iowa Institute for Oral Health Research, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA. [email protected].
  2. Cellworks Research India Ltd., Whitefield, Bangalore, 560066, India.
  3. Biomedical Engineering, The University of Iowa, 5318 SC, Iowa City, IA, 52242, USA.
  4. Iowa Institute for Oral Health Research, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA.
  5. Division of Biostatistics and Research Design, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA.
  6. Division of Hematology/Oncology, Columbia University Medical Center, 177 Fort Washington Avenue, New York, NY, 10032, USA.
  7. Molecular Pathology Laboratory, Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., C606GH, Iowa City, IA, 52242, USA.
  8. Clinical Services, Experimental Therapeutics, Melanoma and Sarcoma Program, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, 52242, USA.
  9. Department of Radiation Oncology, Human Oncology and Pathogenesis Program, Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  10. Cellworks Group, Inc., 2033 Gateway Place Suite 500, San Jose, CA, 95110, USA.

PMID: 29649990 PMCID: PMC5898039 DOI: 10.1186/s12885-018-4200-5

Abstract

It has been highlighted that in the original manuscript [1] Table S3 'An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways' was omitted and did not appear in the Additional files and that the Additional files were miss-numbered thereafter. This Correction shows the correct and incorrect Additional files. The original article has been updated.

References

  1. BMC Cancer. 2018 Feb 27;18(1):225 - PubMed

Publication Types

Grant support